Mora Kallner

451 total citations
15 papers, 373 citations indexed

About

Mora Kallner is a scholar working on Oncology, Surgery and Epidemiology. According to data from OpenAlex, Mora Kallner has authored 15 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Surgery and 5 papers in Epidemiology. Recurrent topics in Mora Kallner's work include Drug Transport and Resistance Mechanisms (9 papers), Cholesterol and Lipid Metabolism (4 papers) and Metabolism and Genetic Disorders (4 papers). Mora Kallner is often cited by papers focused on Drug Transport and Resistance Mechanisms (9 papers), Cholesterol and Lipid Metabolism (4 papers) and Metabolism and Genetic Disorders (4 papers). Mora Kallner collaborates with scholars based in Sweden. Mora Kallner's co-authors include Kjell Hellström, Kurt Einarsson, Bo Angelin, B Beermann, Lars-Olof Eriksson, Kurt Bergström and G Lundh and has published in prestigious journals such as Journal of Clinical Investigation, Clinical Pharmacology & Therapeutics and Clinica Chimica Acta.

In The Last Decade

Mora Kallner

14 papers receiving 304 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mora Kallner Sweden 11 221 179 152 85 52 15 373
D Panveliwalla United Kingdom 7 224 1.0× 92 0.5× 139 0.9× 42 0.5× 22 0.4× 12 407
Rossella Iori Italy 11 266 1.2× 287 1.6× 145 1.0× 30 0.4× 57 1.1× 14 476
Franca Zironi Italy 7 221 1.0× 218 1.2× 103 0.7× 29 0.3× 40 0.8× 8 342
D Trülzsch United States 10 344 1.6× 195 1.1× 231 1.5× 111 1.3× 30 0.6× 16 709
Rick Havinga Netherlands 10 275 1.2× 238 1.3× 115 0.8× 42 0.5× 79 1.5× 12 539
G. Hedenborg Sweden 11 162 0.7× 104 0.6× 90 0.6× 36 0.4× 19 0.4× 32 360
Jan‐Erik Åkerlund Sweden 11 176 0.8× 304 1.7× 76 0.5× 28 0.3× 57 1.1× 12 432
Sidney Emerman United States 6 237 1.1× 120 0.7× 50 0.3× 63 0.7× 26 0.5× 8 367
Christine Talos Switzerland 8 204 0.9× 110 0.6× 218 1.4× 102 1.2× 20 0.4× 8 570
Paolo Bacchin United States 6 161 0.7× 51 0.3× 91 0.6× 61 0.7× 31 0.6× 8 374

Countries citing papers authored by Mora Kallner

Since Specialization
Citations

This map shows the geographic impact of Mora Kallner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mora Kallner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mora Kallner more than expected).

Fields of papers citing papers by Mora Kallner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mora Kallner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mora Kallner. The network helps show where Mora Kallner may publish in the future.

Co-authorship network of co-authors of Mora Kallner

This figure shows the co-authorship network connecting the top 25 collaborators of Mora Kallner. A scholar is included among the top collaborators of Mora Kallner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mora Kallner. Mora Kallner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Eriksson, Lars-Olof, B Beermann, & Mora Kallner. (1987). Renal function and tubular transport effects of sulindac and naproxen in chronic heart failure. Clinical Pharmacology & Therapeutics. 42(6). 646–654. 9 indexed citations
2.
Beermann, B, et al.. (1986). A Double Blind Comparison of Naproxen and Sulindac in Female Patients with Heart Failure. Scandinavian Journal of Rheumatology. 15(sup62). 32–35. 1 indexed citations
3.
Beermann, B, et al.. (1985). Aspects of the Effects or NSAID’s on Renal Function in Congestive Heart Failure. Birkhäuser Basel eBooks. 17. 99–103. 1 indexed citations
4.
Angelin, Bo, Kurt Einarsson, Kjell Hellström, & Mora Kallner. (1976). Elimination of Cholesterol in Hyperlipoproteinaemia. Clinical Science. 51(4). 393–397. 29 indexed citations
5.
Kallner, Mora. (1975). The effect of chenodeoxycholic acid feeding on bile acid kinetics and fecal neutral steroid excretion in patients with hyperlipoproteinemia types II and IV.. PubMed. 86(4). 595–604. 21 indexed citations
6.
Einarsson, Kurt, Kjell Hellström, & Mora Kallner. (1974). Randomly tritium-labelled chenodeoxycholic acid as tracer in the determination of bile acid turnover in man. Clinica Chimica Acta. 56(3). 235–239. 15 indexed citations
7.
Einarsson, Kurt, Kjell Hellström, & Mora Kallner. (1974). The Effect of Cholestyramine on the Elimination of Cholesterol as Bile Acids in Patients with Hyperlipoproteinaemia Type II and IV. European Journal of Clinical Investigation. 4(6). 405–410. 21 indexed citations
8.
Einarsson, Kurt, Kjell Hellström, & Mora Kallner. (1974). Effect of cholic acid feeding on bile acid kinetics and neutral fecal steroid excretion in hyperlipoproteinemia (types II and IV). Metabolism. 23(9). 863–873. 21 indexed citations
9.
Einarsson, Kurt, Kjell Hellström, & Mora Kallner. (1974). The Effect of Cholestyramine on the Elimination of Cholesterol as Bile Acids in Patients with Hyperlipoproteinaemia Type II and IV. European Journal of Clinical Investigation. 4(1). 405–410. 47 indexed citations
10.
Einarsson, Kurt, Kjell Hellström, & Mora Kallner. (1974). Bile Acid Kinetics in Relation to Sex, Serum Lipids, Body Weights, and Gallbladder Disease in Patients with Various Types of Hyperlipoproteinemia. Journal of Clinical Investigation. 54(6). 1301–1311. 103 indexed citations
11.
Einarsson, Kurt, Kjell Hellström, & Mora Kallner. (1974). Influence of Deoxycholic Acid Feeding on the Elimination of Cholesterol in Normolipaemic Subjects. Clinical Science. 47(5). 425–433. 20 indexed citations
12.
Einarsson, Kurt, Kjell Hellström, & Mora Kallner. (1973). The Effect of Clofibrate on the Elimination of Cholesterol as Bile Acids in Patients with Hyperlipoproteinaemia Type II and IV. European Journal of Clinical Investigation. 3(4). 345–351. 32 indexed citations
13.
Bergström, Kurt, Kjell Hellström, Mora Kallner, & G Lundh. (1973). Familial Pancreatitis Associated with Hyperglycinuria. Scandinavian Journal of Gastroenterology. 8(3). 217–223. 10 indexed citations
14.
Hellström, Kjell, et al.. (1973). [Liver damage in connection with ajmaline treatment].. PubMed. 70(13). 1288–90. 2 indexed citations
15.
Einarsson, Kurt, Kjell Hellström, & Mora Kallner. (1973). Feedback regulation of bile acid formation in man. Metabolism. 22(12). 1477–1483. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026